Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability

J Child Adolesc Psychopharmacol
April 2008
https://www.ncbi.nlm.nih.gov/pubmed/?term=18439113

Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study

J Am Acad Child Adolesc Psychiatry
February 1995
https://www.ncbi.nlm.nih.gov/pubmed/7896655

Objective: This study evaluated the efficacy and safety of naltrexone, an opiate blocker, in the treatment of autism.

Efficacy and safety of naltrexone use in pediatric patients with autistic disorder

Ann Pharmacother
June 2006
https://pubmed.ncbi.nlm.nih.gov/16735648/

Objective: To review the efficacy and safety of naltrexone in pediatric patients with autistic disorder (AD).

The effects of naltrexone in autistic children: report of two cases

Turk J Pediatr
Jan-Mar 1995
https://pubmed.ncbi.nlm.nih.gov/7732604/

Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study

Psychiatry Res
1995
https://pubmed.ncbi.nlm.nih.gov/8570775/

Placebo-controlled acute dosage naltrexone study in young autistic children

Preliminary study of altered skin temperature at body sites associated with self-injurious behavior in adults who have developmental disabilities (Abstract)

Am J Ment Retard
July 2001
https://pubmed.ncbi.nlm.nih.gov/11414874/

Erratum: in Table 1 a column heading was inadvertently omitted. See Am J Ment Retard 2001 Sep;106(5):469

Naltrexone plasma levels, clinical response and effect on weight in autistic children

Psychopharmacol Bull
1994
https://pubmed.ncbi.nlm.nih.gov/7831456/

Naltrexone in autistic children: a double-blind and placebo-controlled study

Psychopharmacol Bull
September 1990
http://www.ncbi.nlm.nih.gov/pubmed/?term=2196621

Effect of naltrexone upon self-injurious behavior, learning and activity: a case study